Autopsy report · NCT01954160
Study of Renal Denervation in Patients With Heart Failure
Cause of deathFutility, also drug or device supply
“DSMB decision based upon noted lack of efficacy in manufacturers pivotal trials.”
Life of this trial
- Registered 3 months before it started.
- Ran for about 1 year before it stopped.
- 5 participants enrolled.
- Results were posted on the registry 1 year 2 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- Adrian Hernandez
- Sponsor type
- University, hospital or other
- Conditions
- Heart Failure
- Interventions
- Symplicity Renal Denervation
- Participants
- 5
- Sites
- 12
- Countries
- United States
Trials that died the same way
- Estrogen Replacement to Reduce Risk of Neurologic Injury After Coronary Artery Bypass Graft Surgery
“DSMB stopped the study based on conclusion of likely futility of treatment on the primary outcome.” - Helping HIV Infected Patients in South Africa Adhere to Drug Regimens
“DSMB stopped trial for futility” - AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
“The DSMB halted the trial prematurely due to futility without any safety concerns.” - Placebo Controlled Study of VS-6063 in Subjects With Malignant Pleural Mesothelioma
“Interim analysis-DSMB stated good safety profile but lack of efficacy” - A Dose Range Finding Study of JNJ-38518168 in Patients With Active Rheumatoid Arthritis in Spite of Treatment With Methotrexate
“The decision was made to prematurely discontinue this trial due to lack of efficacy.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.